Home - Products - Others - Other Targets - 2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-

2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-

CAS No. 213473-00-8

2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-( Meridianin C )

Catalog No. M29544 CAS No. 213473-00-8

2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- is a marine derived natural products found in Aplidium meridianum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 41 In Stock
5MG 34 In Stock
10MG 50 In Stock
25MG 90 In Stock
50MG 138 In Stock
100MG 213 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)-
  • Note
    Research use only, not for human use.
  • Brief Description
    2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- is a marine derived natural products found in Aplidium meridianum.
  • Description
    2-Pyrimidinamine, 4-(5-bromo-1H-indol-3-yl)- is a marine derived natural products found in Aplidium meridianum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Meridianin C
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    213473-00-8
  • Formula Weight
    289.13
  • Molecular Formula
    C12H9BrN4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    BrC=1C=CC=2NC=C(C=3N=C(N=CC3)N)C2C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MNITMT

    MNITMT is a potent immunosuppressive agent without bone marrow toxicity .

  • DL-Syringaresinol

    (+)-Syringaresinol shows inhibitory activity of Helicobacter pylori motility with the IC50 value is 50 microg/ml.

  • Bintrafusp alfa

    Bintrafusp alfa (M7824) is a bifunctional fusion protein consisting of the extracellular structural domain of TGF-βRII (a TGF-β “trap”) fused to a monoclonal antibody against human immunoglobulin G1 fused to programmed death ligand 1 (PD-L1).